Preclinical efficacy and intermediate biomarker assays

Ended Definitive Contract Awarded Last action

Contract number
HHSN261200433008C
Awardee
Awarding agency
Obligated
$12,139,180

Award facts

Opportunity
  • N01CN25007 Solicitation number
Contract value 29% obligated
$42,161,360.77 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers
Pricing
Cost No Fee
Place of performance
University City, MO 63130, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 15 -$26,244
Other Administrative Action 14 $0
Other Administrative Action 13 · Preclinical efficacy and intermediate biomarker assay -$355,106
Other Administrative Action 12 · Critical functions TAS::75 0849:: TAS $0
Other Administrative Action 11 $0
Exercise an Option 10 $0
Supplemental Agreement for work within scope 9 · TAS::75 0849:: TAS $0
Funding Only Action 8 $1,350,829
Supplemental Agreement for work within scope 7 $1,993,314
Funding Only Action 6 $1,406,468
Funding Only Action 5 $265,921
Funding Only Action 4 $1,617,000
Funding Only Action 3 $1,617,585
Funding Only Action 2 $1,776,389
Funding Only Action 1 $743,491
Original award $1,749,532
Show all 16

About this award

Written by GovTribe AI ·

This is a $42,161,360.77 definitive contract awarded by the National Cancer Institute, a civilian federal agency, to The Washington University's Office of Sponsored Research Services Division. The contract is for preclinical efficacy and intermediate biomarker assays, which indicates the university is providing scientific research and development services to the agency. The contract has no set-aside designation, as Washington University is a large, private research institution. This award appears to be part of the university's extensive portfolio of federal research contracts and grants, which span disciplines like biomedical research, engineering, and physics. Washington University has a history of collaborating with agencies such as the Department of Defense, Department of Veterans Affairs, and NASA on specialized R&D projects through both prime and subcontractor roles.

Quick answers

Who was awarded contract HHSN261200433008C?

HHSN261200433008C was awarded to The Washington University by National Cancer Institute (National Institutes of Health) on May 15, 2004.

How much is contract HHSN261200433008C worth?

The government has obligated $12,139,180 on HHSN261200433008C. Its current value, with exercised options, is $42,161,361.

Was contract HHSN261200433008C competed?

The extent of competition for HHSN261200433008C was full and open competition. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login